(Shinjuku-ku, Tokyo, CEO: Kazuhiro Hasegawa, hereinafter referred to as "Glocalink") raised funds on 12/28/2016 through a third-party allotment of new shares with Glocalink as the underwriter to Integriculture Corporation, which aims to promote "pure meat," meat produced through cell culture. The company has raised funds through a third-party allotment of shares to Glocalink on 12/28/2016.

With a total of 4.96 million yen in development funds obtained through this fundraising, the company will aim for the early introduction of pure meat to the market by making the culture fluid, which constitutes the majority of raw materials, free of animal-derived ingredients and at a lower price, and by accelerating the development of reflux culture technology that enables large-scale use of this culture fluid.

For more information, please see below (orIntegriculture web(see below).

record

Notice of Fundraising through Third-Party Allotment of New Shares
- Accelerate commercialization of meat production through cell culture by increasing development funding - Accelerate commercialization of meat production through cell culture by increasing development funding

 Integral Culture Corporation (Head office: Bunkyo-ku, Tokyo; Representative Director: Yuki Hanyu; hereinafter referred to as "the Company"), which aims to promote "pure meat" (cultured meat) produced by cell culture. (headquartered in Bunkyo-ku, Tokyo; Yuuki Hanyu, President; hereinafter referred to as "the Company") won the Grand Prize in the "2nd Agriscience Grand Prix" hosted by Liverness Corporation, and was entitled to receive the prize money and 5 million yen for business investment. Furthermore, on 12/28/2016, the Company exercised this right and raised funds through a third-party allotment of new shares to GLOKA Link Corporation, a subsidiary of RIVANES Corporation.
1. our development experience
By offering "pure meat," meat produced by cell culture, at a price point affordable by consumers, we aim to eliminate the environmental impact and public health risks of meat production and provide a sustainable means of supplying the world's growing demand for meat.
To realize our vision, we are developing technologies to lower the cost of culture medium, which constitutes the majority of raw material costs, and to increase the scale of cell culture.
To produce pure meat using conventional cell culture methods costs several million yen for 100g. To solve this problem, we have developed a technology to reduce the cost of producing pure meat to about 40,000 yen by creating a prototype of a low-cost, animal-derived component-free culture medium and a culture system that can operate this medium on a large scale using a flow process.

2. future commercialization plans
The most significant feature of our low-cost culture fluid, which contains no animal-derived ingredients, and the culture technology that enables large-scale operation of this fluid, is the ability to mass produce pure meat at a low cost.
As a result of interview surveys conducted with many research institutes and businesses, we have determined that the biggest challenges in pure meat production lie in scaling up the production system and reducing the cost of raw materials, and we have worked to develop our own low-cost culture solution and reflux culture technology (patented) that can be scaled up to a large scale.
Going forward, with the development funds, including the funds received from this financing, we aim to achieve price reductions and large-scale production systems in stages, with the goal of producing a prototype of cultured foie gras by the end of 2018 and bringing it to market in 2021.
By 2025, we will achieve price parity with the current price of ordinary meat, and will realize a sustainable means of supply to meet the ever-increasing global demand for meat, thereby contributing to food safety around the world.

■About Our Low-Cost Cultures
By replacing fetal bovine serum (FBS) contained in the current culture medium with "FBS substitute" made from ordinary food, this culture medium does not contain any animal-derived ingredients and is much less expensive.
When used with the patented culture system (described below), the cost of the culture solution required to produce pure meat can be reduced to less than 10 yen per liter, or 1/10,000th of the cost of conventional systems.

■Our culture system
By simultaneously culturing cells that emit components that promote cell proliferation and muscle cells, etc., this system greatly enhances the efficacy of the above low-cost culture medium and enables efficient production of pure meat. Unlike current disposable batch-type systems, our culture system performs cell culture in a continuous flow system, allowing for scale-up through parallelization and larger scale production.

About ■About Integriculture Inc.
Founded: October 2015 Representative Director: Yuki Hanyu
By developing a flow-based large-scale cell culture system using low-cost serum-free medium,The company has achieved a breakthrough in reducing the price of pure meat to 1/1000 of the conventional price. Further development is underway.
https://www.integriculture.co/

Since 2012, Glocalink has been investing in and fostering the development of prototypes for companies that are the recipients of the TECH PLANTER seed acceleration program run by its parent company, LIVERNESS Corporation. GLOCA-LINK will continue to find companies to support through TECH PLANTER, which will be held again this year.
TECH PLANTER Home Page　https://techplanter.com/
In addition, Integriculture Inc. won the Grand Prize in the 2nd "Agri-Deep Tech Grand Prix".